167 filings
8-K
MLNTQ
Melinta Therapeutics, Inc. /New/
20 Apr 20
Bankruptcy or Receivership
7:50am
8-K
MLNTQ
Melinta Therapeutics, Inc. /New/
14 Apr 20
In the United States Bankruptcy Court for the District of Delaware
5:27pm
8-K
MLNTQ
Melinta Therapeutics, Inc. /New/
18 Feb 20
Other Events
12:00am
8-K
MLNTQ
Melinta Therapeutics, Inc. /New/
8 Jan 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:39pm
8-K
MLNTQ
Melinta Therapeutics, Inc. /New/
27 Dec 19
Melinta Therapeutics Announces Restructuring Support Agreement with its Secured Lenders under its Senior Credit Facility
9:03am
8-K
f3qsv7kvtrw4q59
6 Nov 19
Other Events
5:27pm
8-K
ecas8jbg qtn0lt79i
24 Oct 19
Other Events
4:05pm
8-K
63b mzt4aqllvmmke
3 Sep 19
Melinta Therapeutics Announces Appointment of Jennifer Sanfilippo to Interim Chief Executive Officer and Director
4:25pm
8-K
xwrszl42
9 Aug 19
Melinta Therapeutics Reports Second Quarter 2019 Financial Results and Provides Business Update
7:37am
8-K
jmzwx9erbxxh 8251i4j
16 Jul 19
Melinta Therapeutics Announces Preliminary Second Quarter 2019 Financial Results and Provides Corporate Update
4:50pm
8-K
ndduhfgjk
1 Jul 19
Entry into a Material Definitive Agreement
5:18pm
8-K
0wuazkt 4tifyg
11 Jun 19
Submission of Matters to a Vote of Security Holders
12:00am
8-K
lgxcyf x917b
7 Jun 19
Other Events
4:31pm
8-K
r71f5ai9a4ess3e2k871
9 May 19
Melinta Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update
4:16pm
8-K
7rrfiidm 6jtwpc6s
13 Mar 19
Melinta Therapeutics Reports Fourth Quarter and Full-Year
4:04pm
8-K
ag57c afyd2
25 Feb 19
Entry into a Material Definitive Agreement
8:15am
8-K
n2v7rh7b kvaqf
21 Feb 19
Melinta Therapeutics AnnouncesOne-for-Five Reverse Stock Split
5:22pm
8-K
kfvwe
4 Feb 19
Melinta Therapeutics Provides Corporate Updates
9:34am
8-K
41uz1jpsbm mghq8a
16 Jan 19
Entry into a Material Definitive Agreement
12:00am
8-K
de5vusuij8gggv2es r0
2 Jan 19
Entry into a Material Definitive Agreement
9:57pm